EMLY
Live / Registered — Registered (as of 20 Dec 2022)
What this means for you
Registered since 20 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90383409
- Registration number
- 6927212
- Mark type
- Stylized text
- Filed
- 15 Dec 2020
- Published for opposition
- 04 Oct 2022
- Registered
- 20 Dec 2022
- Attorney of record
- John W. McIlvaine, Registration No. 34,219
Goods and services
- Class 042 — Scientific and technological services: Scientific laboratory services; computer system analysis in relation to computerised data; analysis of medical data for scientific and medical research and development purposes; scientific laboratory services, namely, t-cell repertoire decoding services for scientific and medical research and development purposes; scientific laboratory services, namely, sequencing of cells for scientific and medical research and development services; Platform as a Service (PaaS) featuring computer software platforms for scientific and medical research and development, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Platform as a Service (PaaS) featuring computer software platforms for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for scientific and medical research and development services, t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for t-cell repertoire decoding, identification of pathogens, immune response and the treatment of disease; Software as a Service (SaaS) services featuring software for predicting, determining and analysing t-cell specificity; Software as a Service (SaaS) services featuring software for describing the profiles of t-cell receptors and t-cell receptor sequences; scientific research, namely, single cell immune profiling and analysis services; scientific research, namely, t-cell specificity analysis services; pharmaceutical research and development services; medical research services, namely, prediction of immune response, identification of pathogens for medical purposes, t-cell repertoire decoding services for medical purposes, and sequencing of cells for medical purposes; information, advisory and consultancy services relating to the aforesaid
- Class 044 — Medical, beauty and agricultural services: Medical services; medical diagnostic services; medical analysis services related to the treatment of patients; analysis of medical data for the diagnosis and treatment of persons; medical services, namely, immunotherapy services; medical care, namely, personalized medical services; provision of medical information; provision of medical information regarding t-cells, identification of pathogens, immune response and the treatment of disease; information, advisory and consultancy services relating to the aforesaid
Owner
- Etcembly Limited, Oxford, GB
- Etcembly Limited, Oxford, GB
- Etcembly Limited, Oxford, GB
Prosecution history
- 20 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 04 Oct 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Oct 2022 — PUBLISHED FOR OPPOSITION
- 14 Sept 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Aug 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 19 Aug 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 12 Aug 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Aug 2022 — EXAMINER'S AMENDMENT ENTERED
- 12 Aug 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Aug 2022 — EXAMINERS AMENDMENT E-MAILED
- 12 Aug 2022 — EXAMINERS AMENDMENT -WRITTEN
- 19 Feb 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 19 Feb 2022 — FINAL REFUSAL E-MAILED
- 19 Feb 2022 — FINAL REFUSAL WRITTEN